Trigeminal Autonomic Cephalgia - An Insight

Verified data

4 min read

Share
Facebook Telegram LinkedIn WhatsApp

Outline

Trigeminal autonomic cephalgia is a type of headache occurring due to the fifth cranial nerve origin. Read below to know more.

Medically reviewed by Dr. Abhishek Juneja
Published At August 5, 2024
Reviewed At August 7, 2024

Education:

BDS

Professional Bio:

Dr. Leona Dafni. M is a General Dentist with five years of clinical experience. She completed her BDS from RVS Dental College and Hospital, Chennai, Tamil Nadu, India in 2018. She has handled multiple cases over the years in all fields of dentistry and is well-trained in dental procedures such as orthodontics, tooth removal, root canal procedure, gold and zirconia crowns, smile designing, and full mouth rehabilitation. She is also a certified provider of clear aligners.

This doctor is not available for online consultations on the platform anymore.

Education:

MD

Professional Bio:

Dr. Abhishek Juneja is a seasoned Neurologist and Diabetologist with expertise in diagnosing and managing neurological disorders and diabetes-related complications. He specializes in preventive care, patient-centered treatment plans, and advanced therapies for conditions like stroke, neuropathy, and metabolic disorders. With a focus on improving quality of life, Dr. Juneja combines clinical precision with compassionate care to support optimal health and long-term wellness for his patients.    

This doctor is not available for online consultations on the platform anymore.

Table of Contents

Introduction:

Trigeminal autonomic cephalalgia is a clinical condition characterized by a headache due to the trigeminal nerve disorder associated with clinical symptoms seen involving one side of the brain. The clinical symptoms are related to the trigeminal nerve functions, like single-side headaches. They include rhinorrhoea (thin mucous discharge from the nose), tearing up of the eye, and miosis (excessive pupil constriction). This condition is often painful, often affecting the brain's normal functioning. There are episodes of frequent pain that linger for a longer time, and because of this reason, the treatment duration varies from person to person. However, with proper diagnosis, treatment plan, and care, the problem can be sorted.

What Are the Different Types of Trigeminal Autonomic Cephalalgia?

The different types of trigeminal autonomic cephalalgia, according to the International Headache Society, include:

  • Cluster Headache: Cluster headaches are severe headaches that recur in cyclical patterns or clusters, typically simultaneously each day. They are differentiated by intense, one-sided irritation, typically around the eye, that can last for weeks or months and is followed by remission periods.

  • Paroxysmal Headache: Paroxysmal headaches are severe headaches that occur abruptly and continue for a few seconds to minutes. They are commonly connected with disorders such as paroxysmal hemicrania or trigeminal neuralgia and affect only one side of the head.

  • Unilateral Headache: Unilateral headaches occur on one side of the head and may be linked to migraines, cluster headaches, or trigeminal neuralgia.

  • Neuralgiform Headache: Neuralgiform headache with paroxysmal episodes can be identified by acute, severe stabbing pain on one side of the face. It encompasses disorders such as trigeminal neuralgia and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tear.

  • Paroxysmal Hemicrania: Paroxysmal Hemicrania is a rare type of headache characterized by frequent, temporary, strong unilateral headaches that are frequently localized around the eye or temple. Indomethacin is often effective in treating these assaults.

How Does Trigeminal Autonomic Cephalalgia Occur?

Trigeminal autonomic cephalalgia occurs when the trigeminal nerve and pituitary gland complex are complex. There is a series of physiological changes occurring, and they include:

  • Activation of the Pituitary Gland: In this condition, several lesions occur in the pituitary gland as a primary symptom, leading to alterations in the sleep-wake cycle and the body's autonomic functions. Eventually, this plays a major role in TACs.

  • Involvement of the Trigeminal Nerve: The trigeminal nerve, the major nerve supply of the face for its motor functions, gets activated during this process, leading to nerve damage followed by pain.

  • Following the above lesions, changes in the body's autonomic functions lead to alteration in the sympathetic and parasympathetic nervous systems (which supply both sensory and nervous functions). Because of this, functions like nasal secretion, lacrimation, ptosis, and conjunctiva functions are altered.

  • Neurogenic Inflammation: This is a process known as neurogenesis, may be a factor in headache pain and other autonomic symptoms. Neurotransmitters that promote vasodilation and inflammation include substance P and calcitonin gene-related peptides.

  • Genetic predisposition and environmental factors may influence the onset and severity of TACs. However, the precise triggers remain unknown.

What Are the Signs and Symptoms of Trigeminal Autonomic Cephalalgia?

As Trigeminal Autonomic Cephalalgia is a group of headache variants, it still has the common symptoms. Clinically, the symptoms of Trigeminal Autonomic Cephalalgia are:

  • Pain in the periorbital region.

  • Unilateral headache.

  • Phonophobia (patients experience sensitivity to sound).

  • Photophobia (patients experience sensitivity to light).

  • Nausea.

  • Vomiting.

  • Migraines like headaches.

  • Pain of the trigeminal nerve.

  • Drooping of eyelids.

  • During this condition, nerve damage affects the upper side of the pituitary gland, which in turn affects the sensation of smell and taste.

How Is Trigeminal Autonomic Cephalalgia Treated?

As TACs are a group of multiple headache disorders, it is necessary to combine treatment with patient education, medical management, and preventive prophylaxis. Their sleep schedule can treat this condition and habits like alcohol consumption or substance abuse. Also, living conditions like low oxygen supply due to elevated altitudes should be mentioned. All these factors clearly show how the patient can be treated. The treatment protocols followed in their way:

It primarily focuses on pain management and oxygen provision. In medically fit patients, medications like Sumatriptan are administered subcutaneously as a primary effort in pain relief. These agents can also be used twice daily without any risk of nerve excitation. For maximum effect, 100 percent oxygen is given rapidly, around 7 to 12 liters. This helps delay the pain for longer hours.

For the reversal of the condition, preventive management is done by providing the following:

The nasal sprays of Sumatriptan (20 mg) and Zolmitriptan (5 mg and 10 mg) work better than the control drug. Given the effectiveness of both the 5 mg and 10 mg doses of Zolmitriptan, it has been recommended that the initial dose for patients with very severe attacks, which occur once a day or on an alternate day, should be managed with 10 mg. The initial dose for patients with more frequent attacks or poor tolerability should be only 5 mg.

Other drugs used in pain management include topical painkillers like Lidocaine (aesthesia) and Dihydroergotamine nasal sprays, a type of alkaloid used for the placebo effect in handling pain. Once these drugs have proven effective, a group of transition drugs is prescribed, and they help in the rapid suppression of these painful attacks that cannot be limited by other means. One such drug is a corticosteroid, which is a steroid medication that can be used for pain relief; however, caution should be taken before prescribing the drug. The other medications include anesthetizing the greater occipital nerve or nerve supplying the forehead through intravenous injection and intravenous administration of Dihydroergotamine.

According to the American Academy of Neurology and the European Federation of Neurological Societies (EFNS), preventive management also includes the use of medications such as Verapamil, Methysergide, Gabapentin, Lithium, Topiramate, Melatonin, and Sodium valproate.

Conclusion:

Trigeminal autonomic cephalalgias (TACs) are a rare type of acute headache that causes intense, unilateral pain and is often accompanied by autonomic signs such as tears, nasal congestion, and eye redness. This category includes cluster headaches, paroxysmal hemicrania, and short unilateral neuralgiform headaches accompanied by conjunctival injection and tears. The management of TAC is tough due to the intensity and frequency of attacks, which can significantly impair quality of life. Indomethacin is a frequent medicine used to treat paroxysmal hemicrania, as is prophylactic and acute therapy for cluster headaches. Despite advances in understanding and treating TACs, it is important to understand their exact mechanisms and causes. However, further research is essential for developing more effective medications and, ultimately, improving the lives of those affected by this condition.

Source Article Iclon Sources Source Article Arrow
Comprehensive Second Opinion

Ask your health query to a doctor online

Neurology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.